BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2860660)

  • 1. Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
    Domino EF
    Psychopharmacology Suppl; 1985; 2():217-23. PubMed ID: 2860660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monkey model of tardive dyskinesia (TD): evidence that reversible TD may turn into irreversible TD.
    Kovacic B; Domino EF
    J Clin Psychopharmacol; 1982 Oct; 2(5):305-7. PubMed ID: 6890075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluphenazine-induced acute and tardive dyskinesias in monkeys.
    Kovacic B; Domino EF
    Psychopharmacology (Berl); 1984; 84(3):310-4. PubMed ID: 6440175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of dyskinesias and other behavioral effects of re-exposure to neuroleptic treatment in social colonies of Cebus apella monkeys.
    Linn GS; Lifshitz K; O'Keeffe RT; Lee K; Camp-Lifshitz J
    Psychopharmacology (Berl); 2001 Jan; 153(3):285-94. PubMed ID: 11271400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia.
    Gunne LM; Bárány S
    Psychopharmacology (Berl); 1979 Jun; 63(3):195-8. PubMed ID: 39307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol-induced tardive dyskinesia in monkeys.
    Gunne LM; Bárány S
    Psychopharmacology (Berl); 1976 Nov; 50(3):237-40. PubMed ID: 826968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of extended depot fluphenazine treatment and withdrawal on social and other behaviors of Cebus apella monkeys.
    Lifshitz K; O'Keeffe RT; Lee KL; Linn GS; Mase D; Avery J; Lo ES; Cooper TB
    Psychopharmacology (Berl); 1991; 105(4):492-500. PubMed ID: 1771217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monkey models of tardive dyskinesia.
    Domino EF; Kovacic B
    Mod Probl Pharmacopsychiatry; 1983; 21():21-33. PubMed ID: 6656784
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of acute dystonia and tardive dyskinesia in cebus monkeys.
    Bárány S; Ingvast A; Gunne LM
    Res Commun Chem Pathol Pharmacol; 1979 Aug; 25(2):269-79. PubMed ID: 115074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental tardive dyskinesia.
    Gunne LM; Häggström JE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):48-50. PubMed ID: 2858481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.
    Gunne LM; Häggström JE; Sjöquist B
    Nature; 1984 May 24-30; 309(5966):347-9. PubMed ID: 6727989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia: are first signs reversible?
    Quitkin F; Rifkin A; Gochfeld L; Klein DF
    Am J Psychiatry; 1977 Jan; 134(1):84-7. PubMed ID: 12666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a primate model for tardive dyskinesia.
    Bárány S; Häggström JE; Gunne LM
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):86-9. PubMed ID: 6846025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia, fluphenazine decanoate, and haloperidol.
    Waddington JL
    Am J Psychiatry; 1982 May; 139(5):703-4. PubMed ID: 7072867
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticholinergics promote neuroleptic-induced tardive dyskinesia.
    Borison RL; Diamond BI
    Adv Biochem Psychopharmacol; 1980; 24():359-61. PubMed ID: 6105786
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluphenazine decanoate and tardive dyskinesia.
    Schiff AA
    Am J Psychiatry; 1982 Jul; 139(7):969-70. PubMed ID: 6124136
    [No Abstract]   [Full Text] [Related]  

  • 17. The pathophysiology of tardive dyskinesia.
    Klawans HL; Carvey P; Tanner CM; Goetz CG
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden death and neuroleptic medication in subhuman primates.
    Domino EF
    Am J Psychiatry; 1985 Jan; 142(1):145. PubMed ID: 2857069
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
    Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N
    J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises.
    Sachdev P; Tang WM
    Aust N Z J Psychiatry; 1992 Dec; 26(4):666-70. PubMed ID: 1362053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.